• Abstract submissions for the ADS program will close midnight on Wednesday 22 May, 2024
• ADS Pincus Taft & ADS President’s Young Investigator Awards supporting documentation submissions close on Wednesday 22 May, 2024
• ADS Best Clinical Presentation Award in memory of Dr Paul Lee supporting documentation submissions close on Wednesday 22 May, 2024 
• Early Bird Registration deadline is at midnight on Monday 1 July, 2024
• ADS ADC Travel Grants supporting documentation is required by Monday 8 July, 2024

Abstract Submissions are now open for the 2023 ADS/ADEA Australasian Diabetes Congress. Submissions for Abstracts will close midnight on Monday 22 May, 2023 (there will be no extension provided). Please visit the Australasian Diabetes Congress website to submit an absract for the ADS stream at Australasian Diabetes Congress 2023 – ADS submission categories

2024 ADS Australasian Diabetes Congress Awards

A number of awards and grants are available for ADS members attending the 2024 Australasian Diabetes Congress that will be held at the Perth Convention & Exhibition Centre, WA from Wednesday 21 to Friday 23 August 2024. 

Please see below for all ADS ADC Awards and Grants on offer for 2024:-

ADS Poster Awards

ADS Poster Awards for both Basic Science and Clinical Research will be on offer during the 2024 ADS/ADEA Australasian Diabetes Congress. ADS Poster Awards are to the value of $500 each.

Eligibility is as follows:

1. A financial member of the ADS (Paid subs for 2024)
2. Applicants must be an early career researcher
3. You must be available to present at the time of the poster session
4. Each applicant must provide a supporting statement including one signed by his/her supervisor or department head, indicating that the work presented is substantially the candidate’s own work

To apply: Please click on ‘ADS ADC Awards Application Form’ and complete the online application form. Please ensure that you have uploaded your supporting documentation. You must tick the box during abstract submission. Please contact Linda Valenzisi from the ADS Secretariat for any further information by email to linda@diabetessociety.com.au

• ADS ADC Awards Application Form

Applications Closing Date: Wednesday 22 May, 2024

ADS Pincus Taft Young Investigator Award

The ADS-Pincus Taft Young Investigator Award is to the value of $2000. The finalists will be categorised into Basic Science and the award will be given to the best oral presentation by a junior ADS member at the Australasian Diabetes Congress as judged by peer review and a committee appointed by the ADS Council.

Eligibility is as follows:

1. A financial member of the ADS for 12 months at the time of application
(Member must have joined as a member of ADS no later than May 2023 and Paid subs for 2024)
2. Applicants must not be more than 2 years beyond the award of a doctoral degree (PhD, MD) or fellowship (FRACP)
3. Each applicant must provide a supporting statement including one signed by his/her supervisor or department head, indicating that the work presented is substantially the candidate’s own work
4. Previous winners of this award are in-eligible to apply
5. Finalist applicants must present work of abstract submitted for the conference; if not they will be in-eligible to receive the award 6-8 applicants will be selected from abstracts to present in the ADS-Pincus Taft Young Investigators Session.

To apply: Please click on ‘ADS ADC Awards Application Form’ and complete the online application form. Please ensure that you have uploaded your supporting documentation. You must tick the box during abstract submission. Please contact Linda Valenzisi from the ADS Secretariat for any further information by email to linda@diabetessociety.com.au

• ADS ADC Awards Application Form

Applications Closing Date: Wednesday 22 May, 2024

ADS President’s Young Investigator Award

The ADS President’s Young Investigator Award is to the value of $2000. The finalists will be categorised into Clinical Research and the award will be given to the best oral presentation by a junior ADS member at the Australasian Diabetes Congress as judged by peer review and a committee appointed by the ADS Council.

Eligibility is as follows:

1. A financial member of the ADS for 12 months at the time of application
(Member must have joined as a member of ADS no later than May 2023 and Paid subs for 2024)
2. Applicants must not be more than 2 years beyond the award of a doctoral degree (PhD, MD) or fellowship (FRACP)
3. Each applicant must provide a supporting statement including one signed by his/her supervisor or department head, indicating that the work presented is substantially the candidate’s own work
4. Previous winners of this award are in-eligible to apply
5. Finalist applicants must present work of abstract submitted for the conference; if not they will be in-eligible to receive the award 6-8 applicants will be selected from abstracts to present in the ADS Presidents Young Investigators Session. 

To apply: Please click on ‘ADS ADC Awards Application Form’ and complete the online application form. Please ensure that you have uploaded your supporting documentation. You must tick the box during abstract submission. Please contact Linda Valenzisi from the ADS Secretariat for any further information by email to linda@diabetessociety.com.au

• ADS ADC Awards Application Form

Applications Closing Date: Wednesday 22 May, 2024

Best ADS Clinical Presentation Award in memory of Dr Paul Lee

The Best ADS Clinical Presentation Award in memory of Dr Paul Lee is to the value of $1,250. The finalists will be categorised into Clinical Research and the award will be given to the best oral presentation by an ADS member at the Australasian Diabetes Congress that will be held at the Perth Convention & Exhibition Centre, WA from Wednesday 21 to Friday 23 August 2024 and judged by peer review and a committee appointed by the ADS Council. 2019 was the inaugural year of this annual award.

Eligibility is as follows:

1. A financial member of the ADS for 12 months at the time of application
(Member must have joined as a member of ADS no later than May 2023 and Paid subs for 2024)
2. Applicants must be a mid-career clinical researcher (4-10 years post-doctoral)
3. Each applicant must provide a supporting statement indicating that the work presented is substantially their own work
4. 6-8 applicants will be selected from the submitted abstracts to present in the award session
5. Previous winners of this award are in-eligible to apply
6. Finalist applicants must present work of abstract submitted for the conference; if not they will be in-eligible to receive the award

• ADS ADC Awards Application Form

To apply: Please click on ‘ADS ADC Awards Application Form’ and complete the online application form. Please ensure that you have uploaded your supporting documentation. You must tick the box during abstract submission.

Please contact Linda Valenzisi from the ADS Secretariat for any further information by email to linda@diabetessociety.com.au 

Applications Closing Date: Wednesday 22 May, 2024

This year a number of ADS Travel Grants will be awarded to junior investigators who have an abstract accepted for presentation at the 2024 Australasian Diabetes Congress that will be held from Wednesday 21 to Friday 23 August 2024. The number and size of grants will be determined according to the number and suitability of applications and the funds available. The travel grants will provide a significant contribution to the individuals travel costs to attend the congress. Applications will be prioritised using abstract review scores.

Eligibility is as follows:

1. A financial member of the ADS for 12 months at the time of application
(Applicant must have joined as a member of ADS no later than July 2023 and Paid subs to 30 June 2025)
2. In training for a higher degree eg. PhD, MD, fellowship or medical specialty
3. Supported by a statement from the candidate’s supervisor or department head indicating the nature of their present position and the availability of other sources of financial support for their registration to the congress
4. Travel Grants will be made directly to the member and not their respective institution
5. Abstracts must be submitted and accepted for sessions within the ADS program only (clinical or basic science)

Note: Applicants must not be in receipt of a grant from any other body to attend the ADS/ADEA Australasian Diabetes Congress or a meeting in association with the ADS/ADEA ADC. 

To apply: Please click on ‘Apply for ADS Travel Grant’ below and complete the online application form and please ensure that you upload your supporting documentation. The successful applicants will be advised in writing one week prior to the congress and travel grants will be paid following the ADC. Please contact Linda Valenzisi from the ADS Secretariat for any further information by email to linda@diabetessociety.com.au 

Apply for the ADS ADC Travel Grant and Upload Supporting Documentation 

Applications Closing Date: Monday 8 July, 2024

Category 2 RACGP QI&CPD points are available for GPs that attend oral plenary and symposium sessions within the congress program. Free communication oral and poster sessions are not accredited for CPD activity. Allocation of two points per hour is permitted for clinical education of up to a maximum of 30 QI&CPD points for the ADC educational activity (over 3 days). General Practitioners are requested to self report to the RACGP to receive the eligible points.

To make enquiries into sponsoring or exhibiting at the 2023 ADC, please contact Nihal Fernandez at The Conference Company via email to nf@theconferencecompany.com or visit the ADC website at Australasian Diabetes Congress 2023 – Sponsorship & Exhibition for further information.

Download the 2024 ADS/ADEA ADC Poster  

Download the ADC 2023 flyer